Nanoprodrug of retinoic acid-modified paclitaxel

Org Biomol Chem. 2017 Nov 22;15(45):9611-9615. doi: 10.1039/c7ob02553j.

Abstract

All-trans-retinoic acid (RA) is a non-toxic physiological metabolite of vitamin A. A paclitaxel (PTX) prodrug (RA-PTX) with high PTX content of 75% was synthesized via an easy condensation reaction. RA-PTX nanoparticles (RA-PTX NPs) were prepared through a nanoprecipitation method which increased the water solubility of PTX. RA-PTX NPs were spherical in shape and exhibited favorable structural stability in both water and the physiological environment. RA-PTX NPs possessed effective cellular uptake as revealed by confocal laser scanning microscopy and exerted potent cytotoxicity. These results highlight the potential of nanomedicines from PTX prodrugs for increasing the drug loading and water solubility of PTX.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • MCF-7 Cells
  • Molecular Structure
  • Nanoparticles / chemistry*
  • Paclitaxel / chemistry*
  • Paclitaxel / pharmacology
  • Particle Size
  • Prodrugs / chemical synthesis*
  • Prodrugs / chemistry
  • Prodrugs / pharmacology
  • Structure-Activity Relationship
  • Surface Properties
  • Tretinoin / chemistry*
  • Tretinoin / pharmacology

Substances

  • Antineoplastic Agents
  • Prodrugs
  • Tretinoin
  • Paclitaxel